Section Editor: Christian Humpel

1. Introduction {#s0005}
===============

Subcortical vascular dementia (VaD) results from cerebral small vessel disease leading to ischemic and hemorrhagic brain tissue damage that can be observed on magnetic resonance imaging (MRI). Such brain lesions are white matter lesions (WML), lacunes and microbleeds (MB). WML are seen on T2/FLAIR weighted MRI as areas of high signal intensity of variable extent. ([Fig. 1](#f0005){ref-type="fig"}A--D). Mild periventricular lines and caps as well as punctate deep lesions are of non-ischemic origin, while early confluent and confluent lesions represent ischemic damage ranging from incomplete to complete tissue loss ([@bb0035]). The prevalence of any WML ranges between 40 and 95%, depending on the study population ([@bb0150]). Conventional risk factors such as age and hypertension explain only a small proportion of the occurrence of WML ([@bb0085]). Lacunes are observed on T2/FLAIR weighted MR images as 3 to 15 mm abnormalities with CSF-equivalent signal intensity ([@bb0060]) ([Fig. 1](#f0005){ref-type="fig"}E). Their frequency ranges between 6 and 20% ([@bb0150]). The third lesion type is MB seen as hypointense or black spots on susceptibility or T2\* weighted MR images due to paramagnetic effects of hemosiderin deposits at the location of the bleeding ([@bb0050]) ([Fig. 1](#f0005){ref-type="fig"}F). In the Rotterdam Scan Study, prevalence of MB increased strongly with age, ranging from 6.5 to 35.7%.

2. Heritability of cerebral small vessel disease {#s0010}
================================================

Although several monogenic forms of cerebral small vessel disease with early onset have been described, the majority of patients with subcortical VaD represents sporadic cases with enhanced aggregation in families but without a clear Mendelian pattern of inheritance. The heritability of a trait gives the proportion of the total phenotypic variance (Vp) in the population which can be explained by genetic differences among individuals (Vg). Importantly, the heritability index is a quotient (h2 = Vg/Vp) and its estimate is high, when there is a strong phenotypic variability due to genetic factors, as well as when there is low phenotypic variability due to environmental factors in a population. Therefore heritability indices strictly apply to the population they have been estimated for. Heritability estimates for these age-related forms have been reported for WML in elderly male twins ([@bb0010]) in a large population based sample of middle aged--elderly sibships ([@bb0005]), within non-Hispanic white and black hypertensive siblings ([@bb0140]), and in siblings discordant for Alzheimer disease ([@bb0015]). In spite of major differences in study design, heritability estimates were comparable among these studies, and were within the range of 50--80%. The heritability of WML may however be dependent on gender and age as reported by the Framingham study with young women having the highest estimates (h2 = 0.9 ([@bb0005]). Bivariate heritability analyses explore the genetic correlation (rg) between traits, which gives the proportion of variance that two traits share due to common genetic factors. The GENOA study showed significant genetic correlations (rg) between WML and mean arterial pressure both in whites (rg = 0.61) and in blacks (rg = 0.40) and with pulse pressure in blacks (0.29; P \< .001). This indicates common genetic components between WML and blood pressure ([@bb0140]). Bivariate heritability analyses also suggested common genetic influences on WML volume and the volume of specific brain regions such as frontal (rg = 0.30) and parietal lobe (rg = − 0.39) ([@bb0025]). Heritability estimates for lacunes and for MB are not available so far.

In order to identify genetic variants contributing to subcortical VaD both association and linkage studies have been performed. These studies mainly focused on WML, but some candidate gene based association studies also investigated lacunes and MB.

3. Linkage studies {#s0015}
==================

So far significant logarithm of the odds (LOD) scores for WML have been found at 4 cM on chromosome 4 ([@bb0020; @bb0130]), in healthy elderly white subjects, and at chromosome 1q24 in hypertensive sibships ([@bb0145]). Suggestive LOD scores by these studies have been reported at 95 cM on chromosome 17 (LOD = 1.78) ([@bb0020]), at 118 cM on chromosome 11, and at 13 cM on chromosome 21 in white, and at 36 cM on chromosome 22 as well as at 58 cM on chromosome 21 in black subjects ([@bb0145]). Bivariate linkage studies identified significant (chromosome 1q24) and suggestive (chromosome 1q42, 10q22--q26, 15q26) shared loci for WML volumes and blood pressure measurements, such as pulse pressure and systolic blood pressure, indicating the presence of genes with pleiotropic effects at these regions ([@bb0065; @bb0145]).

4. Association studies {#s0020}
======================

Association studies aim to identify genetic variants explaining phenotypic variations in a trait or in susceptibility to a disease in the population. The most frequently investigated genetic variants are the single nucleotide polymorphisms (SNPs), which are bi-allelic variants in the human genome involving a nucleotide exchange. The phenotypes investigated by association studies are either qualitative or quantitative. In case of dichotomized outcomes the effect size estimates of the variant is given as the odds ratio (OR) in those carrying the variant allele compared to non-carriers. If an observed genetic association is true, then it implies that either the investigated variant is causal (direct association) or there is a causal variant in linkage disequilibrium with the investigated one in its neighborhood (indirect association). Importantly, observed associations in one sample must be replicated in independent samples in order to reduce the likelihood of false positive findings, which had discredited association studies in early days. Association studies performed according to published guidelines ensure high quality and have substantially contributed to our understanding of subcortical VaD. During the last two decades numerous association studies using the candidate gene approach have focused on pathways hypothesized to be involved in the pathogenesis of cerebral small vessel disease. According to a recent meta-analyses 46 candidate gene studies investigating variants in 19 genes have been performed ([@bb0090]). [@bb0080] reviewed studies investigating genes involved in vascular dysfunction in cerebral small vessel disease such as *EDN1*, *MHTFR*, and *NOS3* (GenBank ID 1906, 4524, 4846). Due to small sample size of the studies and lack of replications, there is little statistical evidence presently that these genes harbor causal variants for subcortical VaD. Recently hypothesis free genome wide approaches became affordable and identified novel genetic variants in pathways not being suspected to be involved in the development of these lesions previously. Here we focus on those candidate genes which are strongly supported by replication studies or functional data and discuss the findings of the first genome wide association (GWA) study ([Table 1](#t0005){ref-type="table"}).

4.1. APOE {#s0025}
---------

APOE (GenBank ID 348) is the only gene, which had been investigated in all three MRI correlates of subcortical VaD. The APOE E4 allele was reported to be associated both with the extent and the progression of WML ([@bb0045; @bb0070]). Contrarily, the Austrian Stroke Prevention Study found a higher prevalence of WML and lacunar infarcts in carriers of the E2 allele ([@bb0105]). The effect of APOE variants on WML may depend on vascular risk factors such as the presence hypertension ([@bb0070]). Homozygosity for the E4 allele was also significantly associated with the presence of lacunes in an isolated population ([@bb0125]). In the Rotterdam study, the presence of *APOE* E4 allele enhanced the risk for cerebral MB ([@bb0100]), but this finding is controversial ([@bb0075]).

4.2. The renin--angiotensin system (RAS) {#s0030}
----------------------------------------

Genes coding for the RAS are excellent candidates for cerebral small vessel disease as RAS is a major regulator of systemic blood pressure, and of cerebral blood flow. Plasma angiotensinogen (*AGT*, GenBank ID 183) synthesized by the liver is processed to angiotensin II (Ang II) by the serial action of renin and angiotensin-converting enzyme (*ACE* GenBank ID 1636). Ang II exerts its effect through the angiotensin receptors (*AGTR* GenBank ID 185). The association of *ACE* I/D polymorphism with WML has been investigated in nine studies including 2396 individuals and the DD genotype remained a significant predictor of WML (OR = 1,95; 95% CI 1,09:3,48) upon meta-analysis ([@bb0090]). The most frequently investigated single nucleotide polymorphism (SNP) in the *AGT* gene is the M235T. Meta-analyses of 6 candidate gene studies including 2702 individuals showed no effect of this SNP on WML ([@bb0090]). In contrast, linkage studies repeatedly implicated the *AGT* locus (1q42) ([@bb0065; @bb0145]) and the recent GWA study had replicated the association between the 235T allele and WML ([@bb0040]). It is likely that the 235T SNP by itself is not causal, and functional variants in linkage disequilibrium are responsible for these findings. One such variant might be a haplotype (-6:a, -20:c, -153:g, -218:g, positions relative to transcriptional start site) at the *AGT* promoter. This haplotype was first described by the Austrian Stroke Prevention Study and was significantly related to the presence of severe WML ([@bb0110]). The association was independent of hypertension and the haplotype enhanced the basal transcriptional activity of the *AGT* promoter in astrocytes but not in hepatocytes suggesting that the association is mediated by an altered activity of the cerebral and not the systemic RAS ([@bb0115]). Recently, a longitudinal study reported that progression rate of WML in elderly men is influenced by polymorphisms in the *AGTR1* and *AGTR2* genes. Homozygotes for the 1166A allele at *AGTR1* showed less change over time than 1166C carriers ([@bb0135]).

4.3. NOTCH3 {#s0035}
-----------

CADASIL is caused by mutations in the *NOTCH3* (GenBank ID 4854) gene ([@bb0055]), which plays a central role in the functional and structural integrity of small arteries ([@bb0030]). Recently sequencing of the *NOTCH3* gene in the Austrian Stroke Prevention Study showed that this gene is highly variable in the elderly with both common and rare SNPs spreading over the gene ([@bb0120]). Common SNPs (rs1043994, rs10404382, rs10423702, rs1043997) were significantly associated with the presence and the progression of WML. The association was confined to hypertensives and was replicated in the Cohorts for Heart and Ageing Research in Genomic Epidemiology Consortium (CHARGE) in an independent sample of 4773 stroke-free hypertensive elderly individuals of European descent. Beside the common SNPs there were 6 non-synonymous rare SNPs (H170R, P496L, V1183M, L1518M, D1823N and V1952M) in this study, which were detected only in subjects with severe WML and which were predicted to be functional by protein modeling tools. Importantly none of these SNPs affected a cysteine residue and none of the subjects carrying these mutations had MRI signs typical of CADASIL. The results on NOTCH3 resembles other studies on complex traits, such as dyslipidemia where genes carrying common variants associated with modest effect in the population also carry rare variants with large effects segregating in families.

4.4. Genome wide association study {#s0040}
----------------------------------

The first GWA study on WML was performed within the CHARGE consortium ([@bb0040]), including 9361 elderly individuals of European descent from 7 community-based cohort studies: the Aging Gene--Environment Susceptibility-Reykjavik Study, the Atherosclerosis Risk in Communities Study, the Austrian Stroke Prevention Study, the Cardiovascular Health Study, the Framingham Heart Study, and 2 cohorts from the Rotterdam Study. Genome wide significant association was identified for 6 SNPs on chromosome 17q25. The findings had been replicated in an independent sample of 1607 AGES-Reykjavik participants and in 1417 elderly white participants from the 3C-Dijon Study in the original report ([@bb0040]) and in 1677 persons of the Rotterdam Study III ([@bb0155]). In the \~ 100 kb long region on chromosome 17 there are several genes with diverse functions such as the 2 tripartite motif-containing genes (*TRIM65* and *TRIM47* GenBank ID 201292, 91107) the WW domain binding protein 2 gene (*WBP2* GenBank ID 23558), the mitochondrial ribosomal protein L38 gene (*MRPL38* GenBank ID 64978), the Fas-binding factor 1 gene (*FBF1* GenBank ID 217335), the acyl-coenzyme A oxidase 1 gene (*ACOX1* GenBank ID 51) and the C-Elegans homolog (*UNC13D* GenBank ID 201294) gene which may account for the association. The study also reported 3 additional SNPs with highly suggestive p-values of \< 5 ∗ 10^− 5^ which were located within genes coding for the polyamine-modulated factor 1 gene (*PMF1* GenBank ID11243), the collagen type XXV alpha gene (*COL25A1* GenBank ID 84570), and the methylenetetrahydrofolate dehydrogenase 1 gene (*MTHFD1* GenBank ID 4522).

5. Summary {#s0045}
==========

The last decade of research on the genetics of cerebral small vessel disease showed that this phenotype is highly heritable over different populations and subgroups. Candidate gene studies provided strong evidence for at least three pathways involved, namely the RAS, the NOTCH3 signaling pathway and pathways related to APOE. These pathways play an important role in the normal functioning of the neurovascular unit by ensuring dynamic communication between astrocytes, vascular smooth muscle cells, pericytes and endothelial cells. It is conceivable that mutations within these genes interfere with normal cellular communications and lead to a dysfunction of the neurovascular unit, which in turn leads to impaired vasoregulation, cerebral autoregulation, and blood brain barrier permeability. This may ultimately result in ischemic parenchymal damage with myelin rarefaction as histopathologically observed in areas of WML. The recent GWA study was successful in identifying common variants at chromosome 17, and pinpointed to possible novel mechanisms leading to WML. Although association studies had been successful in identifying many common genetic variants, these variants have small effect sizes, odds ratios are typically below 2, and are therefore not useful in clinical settings. Common variants identified so far also explain only a small proportion of the heritability. The same is true for genetic variants that have been identified for other dementia types including Alzheimer\'s disease. Other than in dementia of the Alzheimer type in which many of the identified susceptibility genes and even of loci identified in GWA studies have been replicated by multiple studies with large sample sizes ([@bb0095]), the genetic architecture of vascular dementia and its subtypes is less well explored. Many of the reported genetic associations seen with vascular dementia-related phenotypes rely on small to mid-sized single studies and replication will be mandatory in order to judge on the robustness of these findings.

This missing heritability might be explained by the fact, that the association studies conducted were designed to test common SNPs with minor allele frequency of ≥ 5%. Other kinds of genetic variations such as rare or even individual SNPs, copy number variations and epigenetic modifications though maybe equally important, have not yet been targeted. An alternative to the "common disease common variants" hypotheses is the "common disease rare variant" hypothesis which supposes that rare variants (minor allele frequency ≤ 1--5%) with large effect size (OR \> 2) segregating in families may substantially contribute to the heritability of common diseases. Linkage studies, which have the highest power to test this hypothesis, had detected significant loci for WML, but the causal variants responsible for the linkage signals have not yet been identified. With the advent of next generation sequencing methods and the comprehensive catalog of rare variants by the 1000 Genomes Project (<http://www.1000genomes.org/page.php>), sequencing these regions in large number of individuals became feasible, and we expect that rare causal variants with a large effect size will be identified in the future.
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![Different lesion types commonly found on MRI scans of elderly people (arrows): (A--E) show Fluid Attenuated Inversion Recovery (FLAIR) sequences where white matter lesions (WML) appear as areas of high signal intensity while cerebrospinal fluid (CSF) signal is suppressed. (A) So-called "caps" located symmetrically around the anterior horns of both lateral ventricles. (B) Punctate WML in the centrum semiovale (CS) of the right hemisphere. (C) Early confluent and (D) confluent WML in the left CS. (E) Lacune seen as CSF-isointense lesion surrounded by a small hyperintense rim in the right CS. (F) shows a T2\* weighted MRI sequence that is sensitive to susceptibility effects of hemosiderin. Spots of low signal intensity correspond to microbleeds in the left basal ganglia and thalamus.](gr1){#f0005}

###### 

Summary of association studies on white matter lesions, lacunes and microbleeds discussed in the text.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Phenotype                  Gene/ref seq Gene ID   SNP rs number        Risk allele      OR/p value                              Sample                                          Reference
  -------------------------- ---------------------- -------------------- ---------------- --------------------------------------- ----------------------------------------------- -----------
  WML burden                 ACE (1636)             I/D                  D/D              OR = 1.95, 95% CI = 1.09--3.48          Meta-analysis of 46 studies                     [@bb0090]

  WML presence               AGT (183)              Promoter haplotype   B/B or B +/A −   OR = 8.0 P = 0.003                      Cohort study in elderly Caucasian               [@bb0110]

  WML burden                                        M235T/rs699          235T             NS                                      Meta-analysis of 6 studies                      [@bb0090]

  WML burden                                        M235T/rs699          235T             P = 0.01                                Meta‐analyses of GWAS in elderly Caucasian      [@bb0040]

  WML progression            AGTR1 (185)            A1166C/rs5186        1166C            P = 0.0002 in males                     Depressed and non-depressed elderly Caucasian   [@bb0135]

  WML progression            AGTR2 (11609)          C3123A               3123A            P = 0.014 in males                      Depressed and non-depressed elderly Caucasian   [@bb0135]

  WML burden                 APOE (348)             ε2/ε3/ε4             ε4 carrier       P = 0.016 in hypertensives.             Cohort study elderly Caucasian                  [@bb0070]

  WML burden                                        ε2/ε3/ε4             ε4 carrier       P = 0.003                               Cohort study elderly Caucasian                  [@bb0045]

  WML and lacunes presence                          ε2/ε3/ε4             ε2/ε3 genotype   OR 3.0.                                 Cohort study elderly Caucasian                  [@bb0105]

  WML presence                                      ε2/ε3/ε4             ε4 carrier       NS                                      Meta-analysis of 24 studies                     [@bb0090]

  Lacunes                    APOE (348)             ε2/ε3/ε4             ε4 +/ε4 +        OR 4.7 p = 0.04                         Genetic isolate, elderly hypertensives          [@bb0125]

  Microbleeds                APOE (348)             ε2/ε3/ε4             ε4 carrier       OR = 1.35, 95% CI = 1.10--1.65          Cohort study elderly Caucasian                  [@bb0100]

  WML presence               NOTCH3 (4854)          rs10404382           1036+846G\>T     OR 1.8 p = 0.02;\                       Cohort study elderly Caucasian                  [@bb0120]
                                                                                          OR 3,2 p = 0.002 in hypertensives                                                       

  WML progression                                   rs10404382           1036+846G\>T     β = 0.087 p = 0.05;\                                                                    
                                                                                          β = 0.136 p = 0.013 in hypertensives;                                                   

  Microbleeds                SORL1 (6653)           rs2282649.           5239+73TT        OR 6.87 p = 0.005                       Genetic isolate, elderly hypertensives          [@bb0125]

  WML burden                 TRIM 47 (91107)        rs3744017            A                p = 7.3 × 10^− 9^                       Meta‐analyses of GWAS in elderly Caucasian      [@bb0040]

  WML burden                 TRIM 65 (201292)       rs3744028            C                p = 4.0 × 10^− 9^                       Meta‐analyses of GWAS in elderly Caucasian      [@bb0040]

  WML burden                 WBP2 (23558)           rs11869977           G                p = 5.7 × 10^− 9^                       Meta‐analyses of GWAS in elderly Caucasian      [@bb0040]
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

WML = white matter lesions; OR = odds ratio; 95% CI = 95% confidence interval; β = regression coefficient; GWAS = genome-wide association study, NS = non significant.
